Tilray Intrinsic Value – Tilray Brands Stock Sees Drop, Underperforms Market on Tuesday
November 27, 2023
🌧️Trending News
Tuesday saw Tilray ($NASDAQ:TLRY) Brands Inc. stock take a hit, significantly underperforming the overall market. Tilray Brands Inc. is a leading cannabis producer and retailer, focusing on the production and distribution of medical and recreational cannabis products, as well as the cultivation and development of hemp-based food, beverages, and health and wellness products. The company has grown rapidly in recent years and has become one of the largest and most successful cannabis companies in North America. The stock decline on Tuesday was likely due to investor concerns over the uncertainty surrounding regulations for cannabis in the United States and other markets.
As the legal landscape continues to evolve, investors have become increasingly cautious when it comes to investing in cannabis-related stocks. This uneasiness has caused a sell-off in many stocks in the sector, including Tilray Brands Inc. Despite the decline in stock on Tuesday, Tilray Brands Inc. remains committed to its mission of providing access to high-quality cannabis products and services for both the medical and recreational markets. The company continues to innovate and explore new opportunities in order to provide the best possible products to its customers.
Share Price
The stock opened at $1.8, and despite an attempt at a rebound during the day, ended with the same price it opened at, down by 1.9% from its last closing price. This loss comes amid a time of shifting opinions of the company and its future prospects. While the stock has risen in value since February, it appears to have stagnated around the $1.8 mark in recent weeks. It remains to be seen if Tilray Brands Inc. can recover from this underperformance and move forward in a positive direction. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Tilray. More…
| Total Revenues | Net Income | Net Margin |
| 650.86 | -1.45k | -77.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Tilray. More…
| Operations | Investing | Financing |
| 38.33 | -309.86 | -39.44 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Tilray. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 4.4k | 1k | 4.67 |
Key Ratios Snapshot
Some of the financial key ratios for Tilray are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 16.9% | 7.2% | -213.3% |
| FCF Margin | ROE | ROA |
| 2.5% | -25.9% | -19.7% |
Analysis – Tilray Intrinsic Value
At GoodWhale, we have conducted an analysis of TILRAY’s fundamentals. Our proprietary Valuation Line has calculated that the fair value of TILRAY share is around $5.1. This means that TILRAY stock is currently trading at $1.8, which is undervalued by 64.8%. Investors should therefore consider taking advantage of this opportunity to buy TILRAY stock at a significantly discounted rate. Tilray_Brands_Stock_Sees_Drop_Underperforms_Market_on_Tuesday”>More…
Peers
Its competitors are IM Cannabis Corp, Cansortium Inc, and Aurora Cannabis Inc.
– IM Cannabis Corp ($NASDAQ:IMCC)
Organigram Holdings Inc. is a Canada-based company, which offers various cannabis products. The company’s portfolio of brands include ANKR Organics, Edison Cannabis Co., Trailer Park Buds, and The Edison Cannabis Company. It operates through its subsidiary, Organigram Inc. The company offers dried cannabis, cannabis oils, capsules, and pre-rolls. It also provides adult-use recreational cannabis in Canada.
– Cansortium Inc ($OTCPK:CNTMF)
Consortium Inc is a publicly traded company with a market capitalization of $41.63 million as of 2022. The company has a return on equity of 25.1%, meaning that it has generated a profit for shareholders of $25.1 million over the past year. Consortium Inc is a leading provider of engineering and construction services, with a focus on the energy, industrial, and infrastructure markets. The company has a strong track record of delivering quality projects on time and on budget, and has a reputation for being a dependable partner for its clients.
– Aurora Cannabis Inc ($TSX:ACB)
Aurora Cannabis Inc is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and the New York Stock Exchange under the ticker ACB. The company produces and sells medical cannabis products in Canada, the European Union, the United Kingdom, and Australia. Aurora also has operations in Brazil.
Summary
Tilray Brands Inc. (TILRAY) saw its stock fall on Tuesday, underperforming the broader market. This decline follows a positive trend that had been seen in the stock over the past few weeks. For investors looking to evaluate the investment potential of TILRAY, it is important to review their financials and assess their competitive position in the industry. They have also seen success in launching new products and expanding their distribution network.
Tilray also benefits from a strong brand presence in the cannabis industry, with a large customer base and partnerships with other leading providers. Despite the recent decline in the stock price, Tilray may still offer investors an attractive opportunity for long-term growth.
